AR017195A1 - Derivados de benzodioxano, benzofurano o benzopirano, proceso para su preparacion, composicion farmaceutica que los contiene y proceso para su preparacion. - Google Patents

Derivados de benzodioxano, benzofurano o benzopirano, proceso para su preparacion, composicion farmaceutica que los contiene y proceso para su preparacion.

Info

Publication number
AR017195A1
AR017195A1 ARP980106182A ARP980106182A AR017195A1 AR 017195 A1 AR017195 A1 AR 017195A1 AR P980106182 A ARP980106182 A AR P980106182A AR P980106182 A ARP980106182 A AR P980106182A AR 017195 A1 AR017195 A1 AR 017195A1
Authority
AR
Argentina
Prior art keywords
alkyl
formula
alkyloxycarbonyloxy
preparation
bivalent radical
Prior art date
Application number
ARP980106182A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR017195A1 publication Critical patent/AR017195A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Derivados de benzodioxano, benzofurano o benzopirano de formula I, una forma estereoquímicamente isomerica de los mismos, una forma de N-oxido del mismo ouna sal de adicion de ácido farmacéuticamente aceptable de los mismos, en donde Alk1 esalquilca rbonilo C1-4, alquilcarbonil C1-4alquiloC1-4, carbonilo,carbonilalquilo C1-4 o alcanodiilo C1-6,opcionalmente sustituido con hidroxi,alquiloxi C1-4,alquilcarboniloxi C1-4,alquilcarboniloxi C1-4alquiloxicarboniloxiC1-4,ocicloalquilcarboniloxi C3-6 al quiloxicarboniloxi C1-4; -Z1-Z2- es un radical bivalente de formula: -CH2- (e-1), -O-CH2- (e-2), -S-CH2- (e-3), -CH2-CH2-(e-4), -CH2-CH2-CH2- (e-5), -CH= (e-6), -CH2-CH= (e-7), -CH2-CH2-CH= (e-8), -CH=CH- (e-9); R1, R2y R3 son cada uno independiente mente seleccionados entre Halquilo C1-6, alquenilo C3-6, alquiloxi C1-6, trihalometilo, trihalometoxi, halo, hidroxi, ciano, nitro, amino, alquilcarbonilamino C1-6, alquiloxicarboniloC1-6, alquilcarboniloxi C1-4,aminocarbonilo, mono- o di(alquilo C1 -6)aminocarbonilo, aminoalquilo C1-6, mono- o di(alquiloC1-6)aminoalquilo C1-6,alquilcarboniloxi C1-4 alquiloxicarboniloxi C1-4, o cicloalquilcarboniloxi C3-6 alquiloxicarboniloxi C1-4; o cuando R1 y R2 estánen átomos de carbonoadyacentes, R1 y R2 tomados juntos pueden formar un radical bivalente de formula: -CH2-CH2-CH2- (a-1), -CH2-CH2-CH2-CH2 (a-2), -CH2-CH2-CH2-CH2-CH2- (a-3),-CH=CH-CH=CH- (a-4), -O-CH2-O- (a-5), -O-CH2-CH2- (a-6), -O-CH2-CH2-O- (a-7), -O-CH2-CH2-CH2- (a-8), -O-CH2-CH2-CH2 -CH2 (a-9); en donde opcionalmente uno o dosátomos de H en el mismo o diferente átomo de carbono pueden ser reemplazados por hidroxi, alquilo C1-4 o CH2OH; R4 es H, alquilo C1-6, o unenlace directo cuando elradical bivalente -Z1-Z2- es de formula (e -6), (e-7) o (e-8); A es un radical bivalente de formula (b1) y (b2), en donde el átomo denitrogeno está conectado a Alk1, y m es 0 o 1; Alk2 es alcanodiilo C1-6; R6 es H, alquilo C1-6, alquilcarbonilo C1-4, alquiloxicarbonilo C1-4, fenilmetilo,alqui laminocarbonilo C1-4, alquilcarboniloxi C1-4 alquiloxicarbonilo C1-4, o cicloalquilcarboniloxi C3-6 alquiloxicarboniloxi C1-4; R5 es un
ARP980106182A 1997-12-05 1998-12-04 Derivados de benzodioxano, benzofurano o benzopirano, proceso para su preparacion, composicion farmaceutica que los contiene y proceso para su preparacion. AR017195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97203808 1997-12-05

Publications (1)

Publication Number Publication Date
AR017195A1 true AR017195A1 (es) 2001-08-22

Family

ID=8229014

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106182A AR017195A1 (es) 1997-12-05 1998-12-04 Derivados de benzodioxano, benzofurano o benzopirano, proceso para su preparacion, composicion farmaceutica que los contiene y proceso para su preparacion.

Country Status (32)

Country Link
US (4) US6133277A (es)
EP (1) EP1036073B8 (es)
JP (1) JP2001525407A (es)
KR (1) KR100591605B1 (es)
CN (1) CN1155597C (es)
AR (1) AR017195A1 (es)
AT (1) ATE334125T1 (es)
AU (1) AU748669B2 (es)
BG (1) BG64624B1 (es)
BR (1) BR9814256A (es)
CA (1) CA2311669C (es)
CO (1) CO5011114A1 (es)
CZ (1) CZ297895B6 (es)
DE (1) DE69835372T2 (es)
EA (1) EA003365B1 (es)
EE (1) EE04438B1 (es)
ES (1) ES2270541T3 (es)
HK (1) HK1028400A1 (es)
HR (1) HRP20000340B1 (es)
HU (1) HU224813B1 (es)
ID (1) ID24616A (es)
IL (1) IL136529A (es)
MY (1) MY124586A (es)
NO (1) NO320727B1 (es)
NZ (1) NZ503603A (es)
PL (1) PL191144B1 (es)
SK (1) SK286268B6 (es)
TR (1) TR200001542T2 (es)
TW (1) TW577886B (es)
UA (1) UA70308C2 (es)
WO (1) WO1999029687A1 (es)
ZA (1) ZA9811081B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
DE60014896T2 (de) * 1999-06-02 2006-02-02 Janssen Pharmaceutica N.V. Pyrrolidinyl, piperidinyl oder homopiperidinyl substituierte (benzodioxan, benzofuran oder benzopyran) derivate
HUP0201404A3 (en) * 1999-06-02 2005-02-28 Janssen Pharmaceutica Nv Aminoalkyl substituted benzodioxan, benzofuran or benzopyran derivatives, pharmaceutical compositions containing them and their use and process for their preparations
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
US6688079B2 (en) 2001-04-18 2004-02-10 Kraft Foods Holdings, Inc. Method for manufacturing flexible packages having slide closures
EP1445324A4 (en) * 2001-11-09 2005-02-16 Kaneka Corp PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMAN DERIVATIVE AND INTERMEDIATE PRODUCT
ES2199086B1 (es) 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
US7071821B2 (en) * 2003-05-14 2006-07-04 Bellsouth Intellectual Property Corporation Method and system for alerting a person to a situation
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
CA2580584C (en) * 2003-09-19 2015-07-28 Galileo Pharmaceuticals, Inc. Use of alpha-tocotrienol for treatment of mitochondrial diseases
BRPI0416817A (pt) 2003-11-20 2007-03-06 Janssen Pharmaceutica Nv 2-quinolinonas e 2-quinoxalinonas 7-fenilalquila substituìdas como inibidores da poli(adp-ribose)polimerase
EA009875B1 (ru) 2003-11-20 2008-04-28 Янссен Фармацевтика Н.В. 6-алкенил и 6-фенилалкил замещенные 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы
ES2238015B1 (es) * 2004-01-30 2006-11-01 Cepa Schwarz Pharma, S.L. Derivados de cicloalcanodionas con actividad neuroprotectora.
CA2569824C (en) 2004-06-30 2013-03-19 Janssen Pharmaceutica N.V. Phthalazine derivatives as parp inhibitors
EP1771422B1 (en) 2004-06-30 2011-02-16 Janssen Pharmaceutica NV Quinazolinone derivatives as parp inhibitors
WO2006003148A1 (en) * 2004-06-30 2006-01-12 Janssen Pharmaceutica N.V. Quinazolinedione derivatives as parp inhibitors
DE102004032277A1 (de) * 2004-07-02 2006-01-19 Basell Polyolefine Gmbh Verfahren zur racemoselektiven Synthese von ansa-Metallocenen
CA2597616A1 (en) 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
EP1874756A1 (en) * 2005-04-22 2008-01-09 Wyeth Chromane and chromene derivatives and uses thereof
WO2008015538A2 (en) * 2006-07-31 2008-02-07 Schwarz Pharma S.L. Use of diaza- and thiaza-cycloalkanediones for preventing and/or treating pain and /or migraine
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US8503431B2 (en) * 2006-08-25 2013-08-06 Wireless Wonders Ltd. Mobile phone related indirect communication system and method
AU2008223793B2 (en) 2007-03-08 2012-08-23 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP and TANK inhibitors
JP5017703B2 (ja) * 2007-05-16 2012-09-05 住友ゴム工業株式会社 ビードエイペックスおよびタイヤ
PL2215075T3 (pl) 2007-10-26 2014-04-30 Janssen Pharmaceutica Nv Pochodne chinolinonu jako inhibitory PARP
EP2260026B1 (en) 2008-03-27 2011-06-22 Janssen Pharmaceutica, N.V. Quinazolinone derivatives as tubulin polymerization inhibitors
EP2271626B1 (en) 2008-03-27 2014-11-26 Janssen Pharmaceutica, N.V. Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors
UA112679C2 (uk) 2012-02-24 2016-10-10 Люпін Лімітед Заміщені хроманові сполуки як модулятори рецептора, чутливого до кальцію
WO2014102592A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Oxime/substituted quinoxaline-type piperidine compounds and uses thereof
DE102013207163B4 (de) 2013-04-19 2022-09-22 Adidas Ag Schuhoberteil
DE102014220087B4 (de) 2014-10-02 2016-05-12 Adidas Ag Flachgestricktes Schuhoberteil für Sportschuhe
WO2017115372A1 (en) 2015-12-30 2017-07-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Pt(IV) PRODRUGS

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
US3929801A (en) * 1973-11-20 1975-12-30 Janssen Pharmaceutica Nv 2-Benzimidazolinones
GB1599296A (en) * 1977-07-06 1981-09-30 Brewster D L Ice making machine
GR71865B (es) * 1978-03-20 1983-07-07 Ciba Geigy
DE2852945A1 (de) * 1978-12-07 1980-06-26 Boehringer Sohn Ingelheim Benzodioxanyl-hydroxyaethylpiperidyl- imidazolidinone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4239348A (en) * 1979-11-30 1980-12-16 Hughes Aircraft Company High resolution AC silicon MOS light-valve substrate
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
DE4319038A1 (de) * 1993-06-08 1994-12-15 Bayer Ag Verwendung von teilweise bekannten substituierten Chromanen als Arzneimittel, neue Wirkstoffe und Verfahren zu ihrer Herstellung
SK282402B6 (sk) * 1993-08-19 2002-01-07 Janssen Pharmaceutica N. V. Deriváty dihydrobenzopyránu, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutický prostriedok na ich báze
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US5696653A (en) * 1996-12-13 1997-12-09 Phase Metrics Tooling for holding a head gimbal assembly
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties

Also Published As

Publication number Publication date
CZ20002018A3 (cs) 2000-10-11
JP2001525407A (ja) 2001-12-11
AU2412799A (en) 1999-06-28
ZA9811081B (en) 2000-06-22
US6852714B2 (en) 2005-02-08
HUP0004492A3 (en) 2002-04-29
HU224813B1 (en) 2006-02-28
EA003365B1 (ru) 2003-04-24
DE69835372T2 (de) 2007-08-09
PL191144B1 (pl) 2006-03-31
NO20002074L (no) 2000-06-02
EE04438B1 (et) 2005-02-15
TR200001542T2 (tr) 2001-01-22
AU748669B2 (en) 2002-06-06
CA2311669A1 (en) 1999-06-17
SK286268B6 (sk) 2008-06-06
SK8032000A3 (en) 2001-02-12
PL341007A1 (en) 2001-03-12
US20030083365A1 (en) 2003-05-01
WO1999029687A8 (en) 2000-04-13
HUP0004492A2 (hu) 2002-03-28
ATE334125T1 (de) 2006-08-15
NO320727B1 (no) 2006-01-23
KR20010031010A (ko) 2001-04-16
KR100591605B1 (ko) 2006-06-20
NZ503603A (en) 2001-10-26
TW577886B (en) 2004-03-01
US20030149093A1 (en) 2003-08-07
US6133277A (en) 2000-10-17
HRP20000340A2 (en) 2001-04-30
BG104372A (en) 2000-12-29
BG64624B1 (bg) 2005-09-30
DE69835372D1 (de) 2006-09-07
HRP20000340B1 (en) 2008-12-31
EE200000328A (et) 2001-08-15
MY124586A (en) 2006-06-30
CZ297895B6 (cs) 2007-04-25
CA2311669C (en) 2010-04-27
CO5011114A1 (es) 2001-02-28
IL136529A0 (en) 2001-06-14
EA200000616A1 (ru) 2000-12-25
US6747045B2 (en) 2004-06-08
WO1999029687A1 (en) 1999-06-17
EP1036073A1 (en) 2000-09-20
UA70308C2 (uk) 2004-10-15
ES2270541T3 (es) 2007-04-01
ID24616A (id) 2000-07-27
CN1280577A (zh) 2001-01-17
BR9814256A (pt) 2000-10-03
IL136529A (en) 2003-03-12
NO20002074D0 (no) 2000-04-19
US6495547B1 (en) 2002-12-17
EP1036073B8 (en) 2006-11-15
EP1036073B1 (en) 2006-07-26
HK1028400A1 (en) 2001-02-16
CN1155597C (zh) 2004-06-30

Similar Documents

Publication Publication Date Title
AR017195A1 (es) Derivados de benzodioxano, benzofurano o benzopirano, proceso para su preparacion, composicion farmaceutica que los contiene y proceso para su preparacion.
DOP2001000270A (es) Agonistas del receptor 3-adrenergico y usos de los mismos
PE20030062A1 (es) Derivados aralquilsulfonil-3-(pirrol-2-ilmetiliden)-2-indolinona como inhibidores de quinasas
ES2187051T3 (es) Benzamidas gastrocineticas biciclicas de derivados de 4-(aminometil)-piperidina sustituidos en posicion 3 o 4.
ES2179353T3 (es) Antagonistas muscarinicos.
AR004699A1 (es) Derivados de 2-quinolina inhibidores de la farnesil transferasa, composicion farmaceutica, proceso para preparar dicha composicion, y proceso para preparar dichos derivados.
UY25142A1 (es) Antagonistas del receptor ccr-3
AR065772A1 (es) Compuestos de indolobenzazepina para el tratamiento de la hepatitis c. composiciones farmaceuticas.
PE20010298A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
AR046711A1 (es) 5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones
NO990912D0 (no) Terapeutiske kombinasjoner av PAR-antagonister og RXR-antagonister og deres anvendelse
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
KR920009823A (ko) 축합 헤테로시클릭 화합물, 그의 제조방법 및 용도
CO5560544A2 (es) Terapia de combinacion para el tratamiento del cancer
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
AR054083A1 (es) Compuestos imidazol y su utilizacion paar preparar medicamentos
MX166594B (es) Composiciones antisepticas que contienen compuestos de hexahidro-5-pirimidinamina y timol y metodos para preparar las mismas
AR012489A1 (es) Tiofenopiridinas antagonistas del factor de liberacion de corticotropina. procedimiento para su preparacion, el uso de las mismas en la preparacionde un medicamento, composicion farmaceutica que las comprende, procedimiento para la preparacion de dicha composicion, un compuesto intermediario y
NO20025640D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
AR072611A1 (es) Compuestos de 3-(fenoxifenilmetil)pirrolidina, un metodo para su preparacion, intermediario de sintesis y su proceso de obtencion, composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de 5-ht y ne.
AR015434A1 (es) Derivados de eritromicina con puente en 6,9, procedimientos para su preparacion, composicion farmaceutica para tratar infecciones bacterianas que los contiene y su uso para la manufactura de un medicamento
ES2176719T3 (es) Derivados de benzopirano que tienen una accion antagonista de leucotrienos.
UY26564A1 (es) Inhibidores del factor xa con aril - amidinas y sus derivados, y composiciones farmacéuticas que contienen los mismos
JPS61277678A (ja) 医薬組成物
AR041720A1 (es) Derivados de n- benzodioxolilo, n- benzodioxanilo y n- benzodioxepinilarilcarboxamida que pueden usarse para el tratamiento de dislipidemia, y composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
FG Grant, registration